Cannabinoid receptor 1 antagonist treatment induces glucagon release and shows an additive therapeutic effect with GLP-1 agonist in diet-induced obese mice

By  

Canadian Journal of Physiology and Pharmacology, Vol. 92, Iss. 12, 2014-01 ,pp. : 975-983

NRC Research Press

Access to resources Recommend Favorite

Is the cannabinoid CB1 receptor antagonist rimonabant advancing the treatment of obesity?

By Doggrell Sheila A  

Expert Opinion on Pharmacotherapy, Vol. 6, Iss. 12, 2005-10 ,pp. : 2141-2144

Informa Healthcare

Access to resources Recommend Favorite

CB1 – Cannabinoid Receptor Antagonist Effects on Cortisol in Cannabis-Dependent Men

By Goodwin Robert S.   Baumann Michael H.   Gorelick David A.   Schwilke Eugene   Schwope David M.   Darwin William D.   Kelly Deanna L.   Schroeder Jennifer R.   Ortemann-Renon Catherine   Bonnet Denis   Huestis Marilyn A.  

The American Journal of Drug and Alcohol Abuse, Vol. 38, Iss. 1, 2012-01 ,pp. : 114-119

Informa Healthcare

Access to resources Recommend Favorite

Discriminative stimulus effects of the cannabinoid CB₁ receptor antagonist rimonabant in rats

By Järbe Torbjörn   Li Chen   Vadivel Subramanian   Makriyannis Alexandros  

Psychopharmacology, Vol. 198, Iss. 4, 2008-07 ,pp. : 467-478

Springer Publishing Company

Access to resources Recommend Favorite

Role of Cannabinoid CB₁ Receptor in Morphine Rewarding Effects in Mice

By Fattore L.   Cossu G.   Mascia M.S.   Obinu M.C.   Ledent C.   Parmentier M.   Imperato A.   Böhme G.A.   Fratta W.  

Pharmacy and Pharmacology Communications, Vol. 6, Iss. 6, 2000-06 ,pp. : 281-285

Pharmaceutical Press

Access to resources Recommend Favorite